These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 8323093

  • 1. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients.
    Chanson P, Weintraub BD, Harris AG.
    Ann Intern Med; 1993 Aug 01; 119(3):236-40. PubMed ID: 8323093
    [Abstract] [Full Text] [Related]

  • 2. Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide.
    Chanson P, Warnet A.
    Metabolism; 1992 Sep 01; 41(9 Suppl 2):62-5. PubMed ID: 1518435
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T, Yokoyama N, Tamai M, Imaizumi M, Kimura H, Tominaga T, Ashizawa K, Kiriyama T, Yoshimine H, Ohishi K, Eguchi K.
    Intern Med; 1998 Dec 01; 37(12):1027-30. PubMed ID: 9932634
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun 01; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas.
    Colao A, Merola B, Ferone D, Marzullo P, Cerbone G, Longobardi S, Di Somma C, Lombardi G.
    Eur J Endocrinol; 1995 Aug 01; 133(2):189-94. PubMed ID: 7655643
    [Abstract] [Full Text] [Related]

  • 9. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
    Chayen SD, Gross D, Makhoul O, Glaser B.
    Horm Metab Res; 1992 Jan 01; 24(1):34-8. PubMed ID: 1612557
    [Abstract] [Full Text] [Related]

  • 10. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ.
    J Clin Endocrinol Metab; 1994 Nov 01; 79(5):1416-23. PubMed ID: 7962337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A, Cakyr B, Azal O, Corakcy A, Kutlu M, Oezata M.
    Endocr Regul; 1999 Dec 01; 33(4):169-74. PubMed ID: 10700085
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF, Liang D, Zhong LY.
    Chin Med J (Engl); 2012 Aug 01; 125(15):2758-63. PubMed ID: 22931988
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995).
    Warnet A, Lajeunie E, Gelbert F, Duet M, Chanson P, Cophignon J, Harris AG.
    Acta Endocrinol (Copenh); 1991 Apr 01; 124(4):487-91. PubMed ID: 2031445
    [Abstract] [Full Text] [Related]

  • 18. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N, Horiguchi K, Nishioka H, Suzuki H, Takeshita A, Takeuchi Y, Inoshita N, Yamada S.
    Endocr J; 2015 Apr 01; 62(1):21-7. PubMed ID: 25273395
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.